Log in

NASDAQ:JAGX - Jaguar Health Stock Price, Forecast & News

$0.88
+0.07 (+8.63 %)
(As of 01/19/2020 04:00 PM ET)
Today's Range
$0.82
Now: $0.88
$1.03
50-Day Range
$0.55
MA: $0.67
$0.88
52-Week Range
$0.52
Now: $0.88
$36.39
Volume4.08 million shs
Average Volume745,907 shs
Market Capitalization$45.05 million
P/E RatioN/A
Dividend YieldN/A
Beta0.8
Jaguar Health, Inc, a commercial stage natural-products pharmaceuticals company, focuses on developing gastrointestinal products for human prescription use and animals worldwide. The company, through its wholly-owned subsidiary, Napo Pharmaceuticals, Inc, focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas. Read More…

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:JAGX
CUSIPN/A
Phone415-371-8300

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$4.42 million
Book Value$5.80 per share

Profitability

Net Income$-32,150,000.00
Net Margins-771.25%

Miscellaneous

Employees40
Market Cap$45.05 million
Next Earnings Date4/8/2020 (Estimated)
OptionableNot Optionable

Receive JAGX News and Ratings via Email

Sign-up to receive the latest news and ratings for JAGX and its competitors with MarketBeat's FREE daily newsletter.


Jaguar Health (NASDAQ:JAGX) Frequently Asked Questions

What is Jaguar Health's stock symbol?

Jaguar Health trades on the NASDAQ under the ticker symbol "JAGX."

How were Jaguar Health's earnings last quarter?

Jaguar Health Inc (NASDAQ:JAGX) issued its earnings results on Thursday, November, 14th. The biotechnology company reported ($1.94) EPS for the quarter, missing the consensus estimate of ($0.25) by $1.69. The biotechnology company earned $0.97 million during the quarter, compared to the consensus estimate of $4.22 million. Jaguar Health had a negative return on equity of 675.03% and a negative net margin of 771.25%. View Jaguar Health's Earnings History.

When is Jaguar Health's next earnings date?

Jaguar Health is scheduled to release their next quarterly earnings announcement on Wednesday, April 8th 2020. View Earnings Estimates for Jaguar Health.

What price target have analysts set for JAGX?

2 Wall Street analysts have issued 1 year target prices for Jaguar Health's shares. Their forecasts range from $3.00 to $5.00. On average, they anticipate Jaguar Health's share price to reach $4.00 in the next twelve months. This suggests a possible upside of 354.1% from the stock's current price. View Analyst Price Targets for Jaguar Health.

What is the consensus analysts' recommendation for Jaguar Health?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Jaguar Health in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Jaguar Health.

Has Jaguar Health been receiving favorable news coverage?

Media stories about JAGX stock have trended very negative this week, according to InfoTrie Sentiment. The research group identifies negative and positive media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Jaguar Health earned a daily sentiment score of -3.0 on InfoTrie's scale. They also assigned news stories about the biotechnology company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for Jaguar Health.

Who are some of Jaguar Health's key competitors?

What other stocks do shareholders of Jaguar Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Jaguar Health investors own include Conatus Pharmaceuticals (CNAT), Biopharmx (BPMX), Cara Therapeutics (CARA), Neovasc (NVCN), Precipio (PRPO), PTC Therapeutics (PTCT), Cascadian Therapeutics (CASC), Biocept (BIOC), Cellectar Biosciences (CLRB) and FuelCell Energy (FCEL).

Who are Jaguar Health's key executives?

Jaguar Health's management team includes the folowing people:
  • Ms. Lisa A. Conte, Founder, CEO, Pres & Director (Age 60)
  • Ms. Karen S. Wright, CFO & Treasurer (Age 63)
  • Dr. Steven R. King, Exec. VP of Sustainable Supply, Ethnobotanical Research & Intellectual Property and Sec. (Age 61)
  • Dr. Pravin R. Chaturvedi, Chair of Scientific Advisory Board & Acting Chief Scientific Officer (Age 56)
  • Mr. Jonathan S. Wolin, Chief Compliance Officer & Corp. Counsel

When did Jaguar Health IPO?

(JAGX) raised $22 million in an initial public offering on Wednesday, May 13th 2015. The company issued 3,200,000 shares at $7.00 per share. Aegis Capital Corp acted as the underwriter for the IPO and CRT Capital and Feltl and Company were co-managers.

How do I buy shares of Jaguar Health?

Shares of JAGX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Jaguar Health's stock price today?

One share of JAGX stock can currently be purchased for approximately $0.88.

How big of a company is Jaguar Health?

Jaguar Health has a market capitalization of $45.05 million and generates $4.42 million in revenue each year. The biotechnology company earns $-32,150,000.00 in net income (profit) each year or ($158.74) on an earnings per share basis. Jaguar Health employs 40 workers across the globe.View Additional Information About Jaguar Health.

What is Jaguar Health's official website?

The official website for Jaguar Health is http://www.jaguaranimalhealth.com/.

How can I contact Jaguar Health?

Jaguar Health's mailing address is 201 MISSION STREET SUITE 2375, SAN FRANCISCO CA, 94105. The biotechnology company can be reached via phone at 415-371-8300.


MarketBeat Community Rating for Jaguar Health (NASDAQ JAGX)

Community Ranking:  4.4 out of 5 (star star star star)
Outperform Votes:  1,798 (Vote Outperform)
Underperform Votes:  241 (Vote Underperform)
Total Votes:  2,039
MarketBeat's community ratings are surveys of what our community members think about Jaguar Health and other stocks. Vote "Outperform" if you believe JAGX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe JAGX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/19/2020 by MarketBeat.com Staff

Featured Article: What are no-load funds?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel